# Efficacy of XP20B Following Bunionectomy Surgery

> **NCT00655291** · PHASE3 · COMPLETED · sponsor: **Xanodyne Pharmaceuticals** · enrollment: 190 (estimated)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** XP20B
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00655291
- **Lead sponsor:** Xanodyne Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2008-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655291, "Efficacy of XP20B Following Bunionectomy Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00655291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*